ACCUPRIL

Active ingredients

The drug ACCUPRIL contains one active pharmaceutical ingredient (API):

UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.

Read about Quinapril

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ACCUPRIL Film-coated tablet
Structured Product Labeling (SPL)
US

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
C09AA06
Quinapril
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA06

Authorization and marketing

This brand name is authorized in the following countries: Australia Canada United States South Africa

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 1968N, 1969P, 1970Q
CA
Health Products and Food Branch
Identifier(s): 01947664, 01947672, 01947680, 01947699
US
FDA, National Drug Code
Identifier(s): 0071-0527, 0071-0530, 0071-0532, 0071-0535
ZA
Health Products Regulatory Authority
Identifier(s): W/7.1.3/361, W/7.1.3/362, W/7.1.3/363, W/7.1.3/364